RPF

1-{4-[3-(2-METHOXY-BENZYLOXY)-PROPOXY]-PHENYL}-6-(1,2,,3,4-TETRAHYDRO-QUINOLIN-7-YLOXYMETHYL)-PIPERAZIN-2-ONE

Created:	2005-02-18
Last modified:	2011-06-04

Find Related PDB Entry
1 entries where RPF is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	76
Chiral Atom Count	1
Bond Count	80
Aromatic Bond Count	18

2D diagram of RPF

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	1-{4-[3-(2-METHOXY-BENZYLOXY)-PROPOXY]-PHENYL}-6-(1,2,,3,4-TETRAHYDRO-QUINOLIN-7-YLOXYMETHYL)-PIPERAZIN-2-ONE
Systematic Name (OpenEye OEToolkits)	(6S)-1-[4-[3-[(2-methoxyphenyl)methoxy]propoxy]phenyl]-6-(1,2,3,4-tetrahydroquinolin-7-yloxymethyl)piperazin-2-one
Formula	C₃₁ H₃₇ N₃ O₅
Molecular Weight	531.643
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C5N(c2ccc(OCCCOCc1ccccc1OC)cc2)C(COc4ccc3c(NCCC3)c4)CNC5
SMILES	CACTVS	3.341	COc1ccccc1COCCCOc2ccc(cc2)N3[CH](CNCC3=O)COc4ccc5CCCNc5c4
SMILES	OpenEye OEToolkits	1.5.0	COc1ccccc1COCCCOc2ccc(cc2)N3C(CNCC3=O)COc4ccc5c(c4)NCCC5
Canonical SMILES	CACTVS	3.341	COc1ccccc1COCCCOc2ccc(cc2)N3[C@@H](CNCC3=O)COc4ccc5CCCNc5c4
Canonical SMILES	OpenEye OEToolkits	1.5.0	COc1ccccc1COCCCOc2ccc(cc2)N3[C@@H](CNCC3=O)COc4ccc5c(c4)NCCC5
InChI	InChI	1.03	InChI=1S/C31H37N3O5/c1-36-30-8-3-2-6-24(30)21-37-16-5-17-38-27-13-10-25(11-14-27)34-26(19-32-20-31(34)35)22-39-28-12-9-23-7-4-15-33-29(23)18-28/h2-3,6,8-14,18,26,32-33H,4-5,7,15-17,19-22H2,1H3/t26-/m0/s1
InChIKey	InChI	1.03	JXFXZCANEQOOHW-SANMLTNESA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL434956
PubChem	11840980
ChEMBL	CHEMBL434956

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.